Mylan gets FDA approval of blood pressure drug
By Alex Nixon
Published: Tuesday, November 13, 2012, 10:34 a.m.
Updated: Tuesday, November 13, 2012
Mylan Inc. said on Tuesday that it gained Food and Drug Administration approval for a generic blood pressure drug.
Cecil-based Mylan said it has started shipping Sildenafil Citrate tablets, the generic version of Pfizer Inc.'s Revatio.
Revatio had U.S. sales of $338.7 million in the 12 months ended Sept. 30.
Alex Nixon is a staff writer for Trib Total Media. He can be reached at 412-320-7928 or firstname.lastname@example.org.
- Rossi: Late-game moves pay off
- Trib poll: Peduto pulling ahead in Pittsburgh mayor’s race
- Militaries’ growing use of ground robots raises ethics concerns
- Kovacevic: Do Senators have anything left?
- Steelers might be forced to rely on rookies in 2013
- Penguins’ Dupuis earns teammates’ respect with consistent play
- Gulf Tower ‘turns’ red over Pens goals
- True primary contests are rare in region
- Leechburg man takes on busy election season
- Low voter turnout expected
- Pirates’ bullpen falters in extra-inning loss to Astros
You must be signed in to add comments
To comment, click the Sign in or sign up at the very top of this page.
Subscribe today! Click here for our subscription offers.